Michael H Serrano-Wu

USPTO Granted Patents = 37 (Patent Applications = 11)

EPO Patents = 17 (Patent Applications = 28)

Average Co-Inventor Count = 5.2

ph-index = 6

Forward Citations = 212(Granted Patents)

Location History:

Guilford, CT (US) (2002 - 2007)
Belmont, MA (US) (2011 - 2024)
Cambridge, MA (US) (2020 - 2024)

Company Filing History:

11 out of 443

The Broad Institute, Inc.

Bayer Aktiengesellschaft

patents

4. 8 out of 378

Bayer Pharma Aktiengesellschaft

patents

5. 7 out of 3,681

Bristol-myers Squibb Compnay

patents

6. 3 out of 6

Anji Pharmaceuticals Inc.

Tabomedex Biosciences, LLC

The General Hospital Corporation

patents

12. 1 out of 1,370

The Brigham and Women's Hospital, Inc.

patents

13. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2025

Loading Chart...

37 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12343334 - Compositions and methods for treating severe constipation (2025-07-01),

2. 12152041 - Macrocyclic fluorine substituted indole derivatives (2024-11-26),

3. 11963960 - Compounds for treating or inhibiting recurrence of acute myeloid leukemia (2024-04-23),

4. 11891404 - Substituted macrocyclic indole derivatives (2024-02-06),

5. 11819495 - Compositions and methods for treating severe constipation (2023-11-21),

6. 11679146 - Compositions and methods for treating pancreatitis (2023-06-20),

7. 11603523 - PCSK9 inhibitors and methods of use thereof (2023-03-14),

8. 11492358 - Macrocyclic indole derivatives (2022-11-08),

9. 11478451 - Macrocyclic chlorine substituted indole derivatives (2022-10-25),

10. 11447504 - Macrocyclic chlorine substituted indole derivatives (2022-09-20),

11. 11440923 - Substituted macrocyclic indole derivatives (2022-09-13),

12. 11401278 - Macrocyclic indole derivatives (2022-08-02),

13. 11286263 - Macrocyclic fluorine substituted indole derivatives (2022-03-29),

14. 11248001 - PCSK9 inhibitors and methods of use thereof (2022-02-15),

15. 11224590 - Compositions and methods for treating severe constipation (2022-01-18),

Sure, I can provide you with an article on inventor Michael H Serrano-Wu.

Title: Innovator Spotlight: Michael H Serrano-Wu from Belmont, MA

Introduction:

Michael H Serrano-Wu is a prolific inventor based in Belmont, MA, with a remarkable portfolio of 34 patents to his name. His innovative contributions span various fields, showcasing his dedication to advancing science and technology.

Latest Patents:

One of Michael H Serrano-Wu's recent patents is for "Substituted macrocyclic indole derivatives," which focuses on compounds beneficial for treating hyperproliferative disorders. Another notable patent is for "Compositions and methods for treating severe constipation," highlighting his commitment to developing solutions for gastrointestinal issues.

Career Highlights:

Throughout his career, Michael H Serrano-Wu has made significant strides in the realms of pharmaceuticals and healthcare. He has been associated with esteemed organizations such as The Broad Institute and Novartis AG, where his expertise has driven groundbreaking research and development efforts.

Collaborations:

Michael H Serrano-Wu has collaborated closely with distinguished professionals in the industry, including Sarah Anna Liesa Johannes and Philipp Buchgraber. These collaborations have fostered a culture of innovation and knowledge-sharing, leading to the creation of impactful inventions and patents.

Conclusion:

In conclusion, Michael H Serrano-Wu stands out as a visionary inventor who continues to push the boundaries of scientific discovery. His impressive patent portfolio and collaborative spirit underscore his commitment to making a tangible difference in the world of healthcare and pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.